Barclays Adjusts Price Target for Legend Biotech While Maintaining Outlook
Legend Biotech Corporation (NASDAQ: LEGN) has been recognized as one of the top healthcare stocks by analysts, despite a recent adjustment in its price target by Barclays. On February 4,…